Abivax (ABVX) EPS (Weighted Average and Diluted) (2024 - 2026)
Abivax (ABVX) recorded quarterly EPS (Weighted Average and Diluted) of -$0.61 in Q1 2026, up 44.22% quarter-over-quarter from -$1.1 in Q4 2025, and up 26.06% on a YoY basis from -$0.48 in Q1 2025.
Abivax (ABVX) EPS (Weighted Average and Diluted) (2024 - 2026) Analysis & Trends
Abivax's EPS (Weighted Average and Diluted) history runs 3 years deep, the most recent figure standing at -$0.61 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 26.06% year-over-year to -$0.61; the TTM figure through Mar 2026 stood at -$0.61 (up 26.06% YoY), while the FY2025 annual figure was -$5.62, down 87.91% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.61 for Q1 2026 at Abivax, up from -$1.1 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.61 in Q1 2026 to a low of -$30449.1 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$9525.4 across 3 years, with a median of -$1.1 in 2025.
- Biggest YoY gain for EPS (Weighted Average and Diluted) was 99.99% in 2025; the steepest drop was 75.56% in 2025.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.62 in 2024, then tumbled by 75.56% to -$1.1 in 2025, then jumped by 44.22% to -$0.61 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.61 (Q1 2026), -$1.1 (Q4 2025), and -$2.1 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.61 |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 6.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.61 |
| Dec 31, 2025 | -1.10 |
| Sep 30, 2025 | -2.10 |
| Jun 30, 2025 | -30,449.06 |
| Mar 31, 2025 | -0.83 |
| Dec 31, 2024 | -0.62 |
| Sep 30, 2024 | -25,450.23 |
| Jun 30, 2024 | -29,823.08 |
| Mar 31, 2024 | -0.68 |